Delayed Gadolinium-enhanced Magnetic Resonance (MR) Imaging of Cartilage - A Pilot Study to Measure the Effect of Adalimumab Plus MTX Versus Placebo Plus MTX on Cartilage in Early RA Patients
Phase of Trial: Phase III
Latest Information Update: 08 Apr 2017
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 04 Apr 2017 Planned End Date changed from 1 Jun 2016 to 1 Jun 2018.
- 04 Apr 2017 Planned primary completion date changed from 1 Oct 2015 to 1 Jan 2018.
- 07 May 2015 Planned End Date changed from 1 Oct 2015 to 1 Jun 2016 as per ClinicalTrials.gov record.